From: Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients
Feature 1 | Feature 2 | Control | sALS | PLS | C9Orf72 | ||||
---|---|---|---|---|---|---|---|---|---|
R | p value | R | p value | R | p value | R | p value | ||
ATP baseline | ATP 2DG delta | 0.922 | 6.45E-37 | 0.924 | 7.07E-71 | 0.941 | 4.61E-15 | 0.648 | n.s. |
ECAR AA-Rot | OCR Max | 0.638 | 9.62E-11 | 0.683 | 6.00E-24 | 0.826 | 2.07E-08 | 0.489 | n.s. |
ECAR baseline | OCR baseline | 0.234 | n.s. | 0.574 | 1.49E-15 | 0.551 | 3.01E-03 | 0.170 | n.s. |
OCR base/ECAR base | ATP baseline | 0.211 | n.s. | −0.017 | n.s. | −0.508 | 7.45E-03 | 0.384 | n.s. |
OCR base/ECAR base | ATP 2DG delta | 0.248 | n.s. | 0.012 | n.s. | −0.491 | 9.53E-03 | 0.264 | n.s. |
OCR baseline | ATP baseline | 0.182 | n.s. | 0.155 | n.s. | −0.434 | 2.42E-02 | 0.445 | n.s. |
ECAR baseline | ATP baseline | 0.012 | n.s. | 0.124 | n.s. | 0.005 | n.s. | −0.148 | n.s. |